Loading...
XSHE
002370
Market cap776mUSD
Dec 05, Last price  
7.36CNY
1D
1.52%
1Q
14.11%
Jan 2017
-49.13%
IPO
12.29%
Name

Zhejiang Yatai Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002370 chart
P/E
160.28
P/S
13.55
EPS
0.05
Div Yield, %
Shrs. gr., 5y
5.00%
Rev. gr., 5y
-10.59%
Revenues
405m
-3.68%
275,801,852342,668,523415,431,739429,667,249435,223,960420,339,304316,044,644313,637,218375,601,838463,145,519762,341,881906,868,6891,132,392,747709,291,124514,885,287315,134,248373,440,356420,643,619405,174,661
Net income
34m
21,457,20439,087,34341,609,95148,152,15342,046,48543,794,83605,480,18140,567,97955,499,28596,800,890139,500,490150,945,987027,274,98700034,239,781
CFO
24m
+66.21%
023,084,220068,261,789048,789,691031,122,81773,312,902100,934,5360127,593,60636,994,829017,806,768012,040,71914,651,74524,353,108
Dividend
Jun 10, 20190.05 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. It offers tablets, capsules, patches, powder injections, and troches. It also provides chemical agents and raw materials, and diagnostic reagents, as well as pharmaceutical research and development outsourcing services. Zhejiang Yatai Pharmaceutical Co., Ltd. was founded in 1989 and is based in Shaoxing, China.
IPO date
Mar 16, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT